Immunotherapy in Bladder Cancer - Alan Bryce

Immunotherapy in Bladder Cancer

Biographies:
E. David Crawford

Alan Bryce, MD is the Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona where he utilizes whole genome sequencing of tumors to identify key driver mutations. His clinical practice centers on genitourinary malignancies (prostate, kidney, bladder, and testicular cancers) and melanoma. Dr. Bryce participates in community outreach to underserved populations and has in interest in health disparities research. He conducts Phase I clinical trials of new cancer drugs.
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe